Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from tertiary care hospitals in India
- PMID: 31219085
- PMCID: PMC6563744
- DOI: 10.4103/ijmr.IJMR_172_18
Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from tertiary care hospitals in India
Abstract
Background & objectives: The increasing prevalence of extended-spectrum β-lactamases (ESBLs) has abated therapeutic options worldwide. This study was undertaken to investigate the molecular profile and resistance patterns of ESBLs among clinical isolates of Escherichia coli and Klebsiella pneumoniae at four tertiary care centres in India.
Methods: Clinical isolates of E. coli and K. pneumoniae were collected from the All India Institute of Medical Sciences (AIIMS), New Delhi; the Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), Puducherry; Postgraduate Institute of Medical Education & Research (PGIMER), Chandigarh and Christian Medical College (CMC), Vellore, over one and a half year period. Antimicrobial susceptibility was determined by Kirby-Bauer disc diffusion method. ESBLs were confirmed phenotypically, and multiplex PCR was performed to identify genes for β-lactamases (blaTEM, blaSHV, blaOXA-1, blaCTXM-1, blaCTXM-2, blaCTXM-9 and blaCTXM-15).
Results: Among 341 E. coli isolates collected during the study period, 171 (50%) harboured blaTEM, 145 (43%) blaOXA-1,70 (21%) blaCTXM-1, 19 (6%) blaSHV and four (1%) harboured blaCTXM-2. Phenotypically, combined disc test detected ESBL production in 98/298 (33%) E. coli. Among 304 K. pneumoniae isolates, 115 (38%), 89 (29%), 83 (27%), 64 (21%) and two (0.6%) harboured blaTEM, blaOXA-1, blaCTXM-1, blaSHV and blaCTXM-2, respectively. Combined disc test (CDT) detected ESBL production in 42 per cent K. pneumoniae. Most of the blaCTXM-1positive isolates were also blaCTXM-15 positive. The carbapenem susceptibility ranged from 56 to 88 per cent for E. coli and from 20 to 61 per cent for K. pneumoniae. Antibiotic sensitivity patterns showed that colistin (CST) was the most sensitive drug for both E. coli (271/274, 99%) and K. pneumoniae (229/234, 98%).
Interpretation & conclusions: The prevalence of ESBL among four study centres varied, and blaTEM, blaOXA-1 and blaCTXM-15 were the most common genotypes in E. coli and K. pneumoniae isolates in India. The growing carbapenem resistance and emerging colistin resistance warrant the judicious use of these antimicrobials.
Keywords: Antibiotic sensitivity; Escherichia coli; Klebsiella pneumoniae; colistin resistance; extended-spectrum β; lactamases.
Conflict of interest statement
None
Similar articles
-
Prevalence of blaTEM , blaSHV and blaCTX-M genes in clinical isolates of Escherichia coli and Klebsiella pneumoniae from Northeast India.Indian J Pathol Microbiol. 2014 Apr-Jun;57(2):249-54. doi: 10.4103/0377-4929.134698. Indian J Pathol Microbiol. 2014. PMID: 24943758
-
Molecular detection and epidemiology of extended-spectrum beta-lactamase genes prevalent in clinical isolates of Klebsiella pneumoniae and E coli from Trinidad and Tobago.West Indian Med J. 2010 Dec;59(6):591-6. West Indian Med J. 2010. PMID: 21702229
-
Extended spectrum beta-lactamases in Escherichia coli & Klebsiella pneumoniae & associated risk factors.Indian J Med Res. 2009 Jun;129(6):695-700. Indian J Med Res. 2009. PMID: 19692752
-
"One Health" perspective on prevalence of co-existing extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae: a comprehensive systematic review and meta-analysis.Ann Clin Microbiol Antimicrob. 2023 Sep 22;22(1):88. doi: 10.1186/s12941-023-00638-3. Ann Clin Microbiol Antimicrob. 2023. PMID: 37740207 Free PMC article. Review.
-
Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia coli or Klebsiella pneumoniae.Pediatr Infect Dis J. 2019 Dec;38(12):e332-e335. doi: 10.1097/INF.0000000000002487. Pediatr Infect Dis J. 2019. PMID: 31738343 Review. No abstract available.
Cited by
-
Comparative Evaluation of Three Phenotypic Tests-Carba NP, Modified Carba NP and Rapidec Carba NP Test for Rapid Detection of Carbapenem Resistance in Blood Culture Isolates of Escherichia coli in an ICU Setting.Malays J Med Sci. 2022 Dec;29(6):60-66. doi: 10.21315/mjms2022.29.6.6. Epub 2022 Dec 22. Malays J Med Sci. 2022. PMID: 36818898 Free PMC article.
-
EVALUATION OF PHENOTYPIC AND MOLECULAR TECHNIQUE IN THE DETECTION OF EXTENDED SPECTRUM BETA-LACTAMASE (ESBL)-PRODUCING GRAM NEGATIVE BACILLI IN OGUN STATE, NIGERIA.Ann Ib Postgrad Med. 2022 Dec;20(2):160-168. Ann Ib Postgrad Med. 2022. PMID: 37384347 Free PMC article.
-
Phenotypic Detection of ESBL, AmpC, MBL, and Their Co-occurrence among MDR Enterobacteriaceae Isolates.J Lab Physicians. 2022 Apr 20;14(3):329-335. doi: 10.1055/s-0042-1744239. eCollection 2022 Sep. J Lab Physicians. 2022. PMID: 36119416 Free PMC article.
-
Antibiotic Resistance Profiles of Escherichia coli and Salmonella spp. Isolated From Dairy Farms and Surroundings in a Rural Area of Western Anatolia, Turkey.Cureus. 2024 Aug 2;16(8):e65996. doi: 10.7759/cureus.65996. eCollection 2024 Aug. Cureus. 2024. PMID: 39221349 Free PMC article.
-
Molecular Characterization of Klebsiella pneumoniae Isolated from Sputum in a Tertiary Hospital in Xinxiang, China.Infect Drug Resist. 2022 Jul 18;15:3829-3839. doi: 10.2147/IDR.S370006. eCollection 2022. Infect Drug Resist. 2022. PMID: 35880230 Free PMC article.
References
-
- Sheng WH, Badal RE, Hsueh PR. SMART Program. Distribution of extended-spectrum β-lactamases, ampC β-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: Results of the study for monitoring antimicrobial resistance trends (SMART) Antimicrob Agents Chemother. 2013;57:2981–8. - PMC - PubMed
-
- Proceedings of the 16th international supplement (M100-S16) Wayne, Pa, USA: CLSI; 2006. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical